View the real-time EVOTEC (EVTG.re) stock quote and decide if you want to buy and when to sell. Find predictions, financials, the latest news and other information to help you with your stock investing.
All investing involves risk
Past performance is not a reliable indicator of future results.
The quantitative stock rating system created by TipRanks shows that EVOTEC price is underperforming. Its Smart Score¹ of 2 indicates EVOTEC is not one of the best stocks to buy now.
Smart Score
Bulls say
Business Recovery
Potential upside exists upon business recovery and as focus assets shift to later stages of development.
Debt Management
Despite the net debt leverage ratio reaching 4.3x, management remains confident about meeting upcoming covenants.
Bears say
Financial Performance
The net debt leverage ratio reached 4.3x, partly due to worsening EBITDA, indicating additional net debt reduction is needed.
Market Uncertainty
There is uncertainty over the timing of clarity on Evotec's 2025+ trajectory, with a risk that no guidance will be provided soon.
The price of EVOTEC today, as of September 9, 2026, was $3.142. That's down -0.30% from the previous session's EVOTEC closing price.
The EVOTEC price is declining this week. Compared to last week, the rate of EVOTEC is down -5.00%, and it's down -14.70% from one month ago.
The 52-week EVOTEC price high is $7.30, while the 52-week EVOTEC price low is $3.10.
Year to date, EVOTEC price is down -46.30% from the beginning of the year and has had a return of -46.30% in the last 12 months.
The sentiment score², indicating how the crowd feels about EVOTEC stock is NEGATIVE. The sentiment signal³ observed at the start of the market session, offering insights into whether EVOTEC stock price today is likely to increase, decrease, or remain steady, is BEARISH.
Table with the sentiment of EVOTEC stock in setembro 2026
Based on analysts giving ratings to EVOTEC stock, the consensus⁴ is BUY. Hedge funds activity⁵ N/A in the last quarter, while Insider activity⁶ trend is bearish (sold EVOTEC shares)
EVOTEC Technical Analysis
Negative-0.46Simple moving average: 20/200 days
Momentum: 12 month change
EVOTEC Insider Activity
sold sharesNet -577K shares last quarter
EVOTEC Fundamentals
-26.0%-13.0%Return on equity: last 12 months
Asset growth: 12 month change
What am I Missing?
Make informed decisions based on real-time data, expert analysis, and powerful research tools from TipRanks.
Access advanced EVOTEC charting, technical analysis, and live market data from TradingView.
Get AI-powered EVOTEC trade signals, in-depth market analysis, and technical strategy insights from Trading Central.
All investing involves risk
Analysts forecast EVOTEC stock price will rise in the next 12 months. Based on 3 Wall Street analysts offering EVOTEC price predictions in the last 3 months, the average price target is $6.03.
The highest EVOTEC stock forecast is $10.00, while the lowest is $3.60. The average EVOTEC price target represents a 90.82% change from the actual price of $3.14.
Overview of stock forecast and price predictions 2026. Analyst price targets and consensus are estimates only and do not constitute guarantees of future outcomes.
There are two ways to invest in EVOTEC stock: trading EVOTEC stock through derivatives like CFDs or buying shares of EVOTEC stock outright. With NAGA.com, you can do both and more.
Buy EVOTEC shares of stock if you want to hold them for a long time. You commit the full value of the EVOTEC shares outright and profit only if they increase in price.
Trade EVOTEC if you want more flexibility — say you want to speculate on its price movements in both directions. With CFDs, you can open a buy position (go long) if you think EVOTEC stock’s price will rise, or you can open a sell position (go short) if you believe the EVOTEC stock’s price will fall.
You won’t need to commit to the full value of the position. But bear in mind that leverage can increase both your profits and losses.
If you want to speculate on EVOTEC price, search for EVOTEC CFD. Then click on the "EVOTEC" symbol to view the chart and other insights before placing your trade. Also, review "EVOTEC" contract specification to be aware of all the EVOTEC CFD trading conditions.
If you want to buy EVOTEC shares outright to hold them for a long time, search for EVOTEC stock with ownership (Real Stocks). Then click on the "EVOTEC" symbol to view the chart and other insights before placing your trade. Also, review "EVOTEC" contract specification to be aware of all the EVOTEC stock buying conditions.
All investing involves risk
EVTG
Evotec
Real Stocks
-0.25%
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
The price of EVOTEC stock today, as of September 9, 2026, was 3.142. That's down -0.30% from the previous session's EVOTEC closing price.
IMPORTANT NOTICE: The content presented in the instrument page is only for informational, educational and support purposes. The material presented, including analyses, sentiment, consensus, prices, opinions or other content, is not an investment recommendation or information that recommends or suggests an investment strategy, nor is it included in the scope of investment advice. NAGA will not accept liability for any loss or damage, including but not limited to any loss of profits, that may arise directly or indirectly from the use of or reliance on the information contained in this page. NAGA is not responsible for the actions or omissions of the client, especially for the acquisition or disposal of financial instruments, made based on the information contained in this page. Past performance is not necessarily indicative of future results, and anyone acting on this information does so at their own risk. ¹ ⁵ ⁶ The Smart Score is a proprietary quantitative stock scoring system created by TipRanks. It assigns stocks a score from one to ten, based on 8 market key factors. The lowest score is 1, and the highest is 10. Stocks with a score of 8, 9, or 10 are considered Outperform, and with a score of 1, 2, or 3 are considered Underperform. The score is data-driven and does not involve any human intervention. The contributing market factors are Wall Street analyst ratings, Corporate insider transactions, Financial blogger opinions, Individual investor sentiment, Hedge fund manager activity, News sentiment, Technicals and Fundamentals. This information is provided for indicative purposes only and should not be interpreted as investment advice or a recommendation to trade. ⁴ ⁷ ⁸ TipRanks’ consensus ratings provide an aggregated view of expectations and consensus on a particular stock from a wide range of global analyst opinions. They’re then condensed into a single indicator, which can help you make investment decisions based on expert analysis. TipRanks’ 12-month forecast is a consensus price target derived from Wall Street analysts’ projections made over the past three months. It forecasts the potential high, low, and average share price for a stock one year from now, along with the average expected upside or downside percentage. ² ³ The sentiment signal and sentiment score are provided by Trading Central. Sentiment insights and market views are based on available data and do not guarantee future performance.
Click the QR code to enlarge
Copyright © 2026 – All rights reserved.
NAGA is a trademark of The NAGA Group AG, a German based FinTech company publicly listed on the Frankfurt Stock Exchange | WKN: A41YCM | ISIN: DE000A41YCM0.
The website is operated by NAGA Markets Europe LTD which is authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC) under licence No. 204/13. The registered address of NAGA Markets Europe LTD is Agias Zonis 11, Limassol 3027, Cyprus. NAGA Markets Europe LTD is also registered with the Romanian Financial Supervisory Authority (“ASF”) with registration no. PJM01SFIM/400019.
RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage of retail investor accounts lose money when trading CFDs with this provider.You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Trading with NAGA Trader by following and/or copying or replicating the trades of other traders involves high levels of risks, even when following and/or copying or replicating the top-performing traders. Such risks include the risk that you may be following/copying the trading decisions of possibly inexperienced/unprofessional traders, or traders whose ultimate purpose or intention, or financial status may differ from yours. Before making an investment decision, you should rely on your own assessment of the person making the trading decisions and the terms of all the legal documentation.
Other group entities: JME Financial Services (Pty) Ltd operates naga.com/za an authorised Financial Services Provider and is regulated by the Financial Sector Conduct Authority in South Africa under license no. 37166.
Key Way Markets Ltd operates naga.com/ae and is authorized and regulated by the Abu Dhabi Global Market (ADGM) Financial Services Regulatory Authority (license no. 190005).
NAGA Capital Ltd operates naga.com/en and is authorised and regulated by the Seychelles Financial Services Authority (FSA) (license no. SD026).
Restricted regions: NAGA Markets Europe LTD offers services to residents within the European Economic Area, excluding Belgium. NAGA Markets Europe LTD does not provide investment and ancillary services in the territories of third countries.
Affiliate programs are not permitted in Spain for the investment service commercialisation or client acquisitions by unauthorised third parties.
Los programas de afiliados no están permitidos en España para la comercialización de servicios de inversión y captación de clientes por parte de terceros no autorizados.
